ClinicalTrials.Veeva

Menu

A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma

Seoul National University logo

Seoul National University

Status

Terminated

Conditions

Carcinoma, Hepatocellular

Treatments

Procedure: Radiofrequency ablation
Procedure: Hepatic resection

Study type

Interventional

Funder types

Other

Identifiers

NCT02482909
0520090

Details and patient eligibility

About

The purpose of this prospective randomized study is to compare the efficacy and safety of radiofrequency ablation and hepatic resection for small hepatocellular carcinomas with very homogeneous underlying conditions.

Enrollment

68 patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age between 20 and 70 years
  2. Child-Pugh class A (score 5-6)
  3. Single hepatocellular carcinoma
  4. Maximal diameter of the tumor from 2 to 4 cm when measured on MRI or CT (The diameter on MRI was measured prior to that on CT)
  5. No previous treatment
  6. Platelet count > 80,000/mm3

Exclusion criteria

  1. HCC abutting main hepatic veins or the first branches of the main portal vein
  2. HCC abutting vessels ≥ 0.5 cm

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

68 participants in 2 patient groups

Hepatic resection
Experimental group
Description:
Hepatic resection is performed as a primary treatment for hepatocellular carcinoma.
Treatment:
Procedure: Hepatic resection
Radiofrequency ablation
Experimental group
Description:
Radiofrequency ablation is performed as a primary treatment for hepatocellular carcinoma.
Treatment:
Procedure: Radiofrequency ablation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems